Piramal Pharma Limited - Asset Resilience Ratio

Latest as of September 2025: 1.37%

Piramal Pharma Limited (PPLPHARMA) has an Asset Resilience Ratio of 1.37% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Piramal Pharma Limited (PPLPHARMA) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

Rs2.22 Billion

≈ $24.06 Million USD Cash + Short-term Investments

Total Assets

Rs161.89 Billion

≈ $1.75 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how Piramal Pharma Limited's Asset Resilience Ratio has changed over time. See what is Piramal Pharma Limited's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Piramal Pharma Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Piramal Pharma Limited stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs2.22 Billion	1.37%
Total Liquid Assets	Rs2.22 Billion	1.37%

Asset Resilience Insights

Limited Liquidity: Piramal Pharma Limited maintains only 1.37% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Piramal Pharma Limited Industry Peers by Asset Resilience Ratio

Compare Piramal Pharma Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Yabao Pharmaceutical Group Co Ltd SHG:600351	Drug Manufacturers - Specialty & Generic	0.27%
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	6.43%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	6.40%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%

Annual Asset Resilience Ratio for Piramal Pharma Limited (2021–2025)

The table below shows the annual Asset Resilience Ratio data for Piramal Pharma Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.12%	Rs195.60 Million ≈ $2.12 Million	Rs156.78 Billion ≈ $1.70 Billion	-0.82pp
2024-03-31	0.94%	Rs1.45 Billion ≈ $15.65 Million	Rs153.12 Billion ≈ $1.66 Billion	+0.94pp
2023-03-31	0.00%	Rs1.00 Million ≈ $10.81K	Rs145.23 Billion ≈ $1.57 Billion	-0.42pp
2022-03-31	0.42%	Rs543.20 Million ≈ $5.87 Million	Rs127.97 Billion ≈ $1.38 Billion	+0.15pp
2021-03-31	0.27%	Rs156.40 Million ≈ $1.69 Million	Rs57.57 Billion ≈ $622.56 Million	--

pp = percentage points

About Piramal Pharma Limited

NSE:PPLPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$2.29 Billion

Rs212.14 Billion INR

Market Cap Rank

#5775 Global

#251 in India

Share Price

Rs160.30

Change (1 day)

-0.97%

52-Week Range

Rs133.27 - Rs219.04

All Time High

Rs293.55